Sana Biotechnology, Inc. (NASDAQ: SANA) is a Healthcare company (Biotechnology) with a market capitalization of $563M. The Maz Rating grades it against the other companies in its sector.
Sana Biotechnology, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.88, Sana Biotechnology, Inc. trades at 3.2x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -97.1%, return on invested capital of -46.4% and a free cash flow yield of -25.8%. On the balance sheet: a debt-to-equity ratio of 0.30 and a current ratio of 1.77. Over the past 52 weeks the share price ranged from $1.84 to $5.49, with a beta of 2.30.
Sana Biotechnology, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 9 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.